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LETTER
Culturing Chlamydophila
pneumoniae
F. WALSH - J. WILLCOCK 1
S.G.B. AMYES
Chlamydophila pneumoniae (formerly
Chlamydia pneumoniae) is an intracellular
pathogen responsible for respiratory tract infec-
tion. A recent British survey of the microbial
aetiology of community-acquired pneumonia
(CAP) indicated that C. pneumonia is responsi-
ble for 13% of CAP and is the second highest
bacterial cause of CAP 1. It has been associated
with bronchitis, pharyngitis, sinusitis, myocardi-
tis, endocarditis and coronary artery disease 2. 
In order to treat C. pneumoniae infections
it is first essential to know the efficacy of the
available antimicrobial agents against this
pathogen. Minimum inhibitory concentration
(MIC) tests are used to investigate the in vitro
capabilities of antimicrobial agents on bacteria.
Therefore, MIC testing of C. pneumoniae
needs to be carried out before an antimicrobial
agent is used to treat the infection. Culturing of
C. pneumoniae must occur before MIC tests
can be performed. C. pneumoniae is known to
be very difficult to culture and is far more diffi-
cult than other chlamydial species 2. Many
methods of culturing C. pneumoniae have
been proposed with differing cell lines, centrifu-
gation conditions and incubation times. There
is no standard method for culturing C. pneu-
moniae nor for testing the MIC of antimicrobial
agents against it. There is no agreement on
optimal culture conditions between different
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laboratories and even within the same laborato-
ry. For C. pneumoniae to be a viable organism
in the sense that it may be tested with regulari-
ty in vitro, a reliable method of culturing is
required. 
Molecular techniques, particularly PCR, are
used to detect C. pneumoniae instead of cul-
turing. However, in the case of antimicrobial
testing this is not an alternative to culturing.
This partly results from the fact that all the pos-
sible mechanisms of antibiotic resistance are
not yet known. Therefore, testing for antibiotic
resistance by investigating the presence or lack
of certain genes is not appropriate. The
absence of genes associated with resistance
does not necessarily mean that the organism is
sensitive to the antimicrobial agent. In contrast,
the presence of a resistance gene does not nec-
essarily mean that it is resistant. Only pheno-
typic testing such as MIC tests will indicate if an
organism is sensitive or resistant. Thus we
return to culturing.
Three different culture methods were inves-
tigated for their reproducibility using four differ-
ent strains. TW 183, ATCC 2023 and AR 39
were collected from the American Type Culture
Collection, the fourth strain, D 1, was received
from Ninewells Hospital, Dundee. The D 1
strain had been successfully cultured using an
in-house culture method in Dundee. All strains
were stored at -70°C. HL (source: the
Washington Research Foundation) and HEp-2
cells were used.
The first method was that of Sriram et al 3,
the second was a method used by Roblin et al
4 and the third method was an in-house
method used by Ninewells Hospital, Dundee, as
described. A monolayer of HL cells were grown
up in shell vials for 24 or 48 hours prior to
inoculation. The growth medium was removed
from the shell vials and the cells were rinsed
with 1-2 mL of filter sterilised phosphate buffer
solution (PBS). Each shell vial was inoculated
with 300 µL of inoculum of TW 183, ATCC
2023, AR 39 or D 1. The vials were then cen-
trifuged at 2400 X g and 35°C for 1 hour. The
medium was replaced with medium containing
1.3 µg/mL cycloheximide. The vials were incu-
bated at 37°C for 7 days with additional cen-
trifugation on days 3, 4 and 5. On day 7 the
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vials were sonicated in an ultrasonicating water
bath. 300 µL of the sonicated medium were
added to freshly prepared monolayers. All neg-
ative controls were processed before examina-
tion of those thought to contain C. pneumoni-
ae. Negative controls consisted of a shell vial
containing uninoculated cells. The cultures were
fixed and stained using direct and indirect anti-
body tests. No inclusions were found in any of
the vials tested. The cells were washed and the
growth medium and PBS were filtered in order
to eliminate bacterial contamination. Three dif-
ferent methods with four different strains, two
different cell lines and two different strains did
not result in identification of a single C. pneu-
moniae inclusion. The lack of inclusions sug-
gests that either the C. pneumoniae were not
viable or the methods used are not easy to
reproduce. As the D 1 strain had previously
been cultured this strain was viable and so
should have resulted in the identification of
inclusions. 
Thus none of the methods attempted could
be reproduced. This lack of reproducibility is a
common problem with C. pneumoniae, and
should be highlighted. Development of new
methods will not alter the problem of C. pneu-
moniae culturing. Standardisation of the exist-
ing methods so that they are reproducible not
only in the same laboratory but also in different
laboratories is the only way that data, particu-
larly information about the antibiotic profile of
C. pneumoniae, may be generated.
Standard, reproducible methods, which are
agreed upon by more than one laboratory are
needed not only for culturing but also for the
investigation of antibiotic resistance in C. pneu-
moniae. A working party of Chlamydophila
scientists is needed that will create culture
guidelines with defined parameters similar to
those available for antimicrobial agent testing.
Thus accurate and valid information on cultur-
ing would be available.
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